AtriCure Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
AtriCure (ATRC) Tops Q2 EPS by 37c
July 28, 2020 4:30 PM EDTAtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.20), $0.37 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $35.95 million.
2020 Financial Guidance
As previously reported, AtriCure is not providing 2020 financial guidance due to the continued... More



